Crinetics Pharmaceuticals
Why Robinhood?
You can watch CRNX and buy or sell other stocks, ETFs, and their options commission-free!About CRNX
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.
CRNX Key Statistics
Stock Snapshot
As of today, Crinetics Pharmaceuticals(CRNX) shares are valued at $84.95. The company's market cap stands at 8.99B, with a P/E ratio of -16.84.
On 2026-10-03, Crinetics Pharmaceuticals(CRNX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.04M.
The stock's 52-week range extends from a low of $32.30 to a high of $85.01.
The stock's 52-week range extends from a low of $32.30 to a high of $85.01.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.